EPCAM and hepatocellular carcinoma: Although the HCC cell line Hep3B has been studied in orthotopic liver microenvironments which show characteristics of human HCC with detectable plasma levels of AFP in BALB/C nude mice [25], no previous study tested if EpCAM expression could affect the tumor-initiating ability of Hep3B cells in an orthotopic mice model.